Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0000899243-23-009168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-20 | 2023-03-16 | AMLX | FRATES JAMES M | CFO | S - Sale | $31.89 | -32.5K | 3,213 | -91% | -$1.04M |
| D | 2023-03-20 | 2023-03-16 | AMLX | FRATES JAMES M | CFO | A - Grant | $0.00 | +21.7K | 23.2K | +1,436% | $0 |
| D | 2023-03-20 | 2023-03-16 | AMLX | FRATES JAMES M | CFO | A - Grant | $0.00 | +97.5K | 97.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-16 | S | D | 1,704 | $32.46 | 1,509 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.33 to $32.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2023-03-16 | S | D | 30,796 | $31.86 | 3,213 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.33 to $32.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2023-03-16 | A | A | 21,667 | $0.00 | 23,176 | D | — | — | (F4) The reported transaction involves the Reporting Person's receipt of a restricted stock unit award (a "RSU"). The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first day of the month of the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. |
| 4 | Derivative | Stock Option (right to buy) | 2023-03-16 | A | A | 97,500 | $0.00 | 97,500 | D | $32.08 · — to 2033-03-16 | 97,500 Common Stock | (F5) 1/4 of the shares subject to the option shall vest and become exercisable on the first day of the month of the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |